No Data
Yixintang Pharmaceutical to Build Logistics Center for 368 Million Yuan
yixintang pharmaceutical (002727.SZ): intends to change some of the raised funds usage and use the raised funds to increase capital to subsidiary for investment projects.
On November 26th, Gelunhui reported that Yixintang (002727.SZ) announced that on November 26, 2024, it held the twelfth meeting of the sixth board of directors and the twelfth meeting of the sixth supervisory board, deliberating and approving the "Proposal on changing the use of some of the raised funds and using the raised funds to increase capital for the subsidiary's investment projects", intending to use 109 million yuan of the raised funds from the company's investment project "Traditional Chinese medicine decoction piece production capacity expansion project" to implement the new project "Yixintang (Sichuan) Health Wisdom Pharmaceutical Base Phase I Logistics Center Project (Phase I)", and increase capital to Yixintang Pharmaceutical (Sichuan) Co., Ltd.
Yixintang Pharmaceutical (002727.SZ): Sichuan Yixintang plans to invest 0.368 billion yuan to construct the large health intelligent pharmaceutical base logistics center project.
On November 26, Gelonghui reported that yixintang pharmaceutical (002727.SZ) announced that, according to the company's global strategy and business positioning, to enhance the company's logistics delivery capacity within Sichuan Province and meet future development needs, the company has agreed that its wholly-owned subsidiary yixintang pharmaceutical (Sichuan) Co., Ltd. (hereinafter referred to as "Sichuan yixintang") will invest 0.368 billion yuan to construct a logistics center project for the health and intelligent pharmaceutical base in Chengdu, Sichuan Province. The new logistics center is expected to meet the business development needs of the company in the Sichuan-Chongqing region.
yixintang pharmaceutical (002727.SZ): plans to increase its investment in shanghai yixintang by 20 million yuan
Grain Alliance reported on November 26th that Yixintang Pharmaceutical (002727.SZ) announced that shanghai Yixintang is the company's controlling subsidiary. In order to promote the business development of shanghai Yixintang, enhance the company's profitability and overall competitiveness, the company plans to increase the capital of shanghai Yixintang by RMB 20 million with its own funds. After this capital increase, the registered capital of shanghai Yixintang will increase from RMB 16.13 million to RMB 36.13 million.
CEO Hong Xian Ruan, Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Largest Shareholder Sees Value of Holdings Go Down 4.6% After Recent Drop
yixintang pharmaceutical (002727.SZ): Currently, some stores of the company have obtained the qualification for outpatient treatment coordination.
On November 12th, yixintang pharmaceutical (002727.SZ) stated on the investor interaction platform that some of the company's stores have obtained clinic coordination qualifications. In the future, the company will strictly carry out corresponding services according to the coordination requirements.
4.8% Earnings Growth Over 3 Years Has Not Materialized Into Gains for Yixintang Pharmaceutical Group (SZSE:002727) Shareholders Over That Period
